Form 4: Nuveen S&P 500 BuyWrite Income Fund: Officer David J. Lamb Reports Transaction

Sentiment:

SEC Form 4 Filing


David J. Lamb, Vice President of Nuveen S&P 500 BuyWrite Income Fund, reports the acquisition of 3,000 shares of common stock at $14.20 per share on February 20, 2025.

Summary

  • On February 21, 2025, a Form 4 filing was submitted to the SEC regarding a transaction by David J. Lamb, Vice President of Nuveen S&P 500 BuyWrite Income Fund (BXMX).
  • The filing reports that Mr. Lamb acquired 3,000 shares of common stock on February 20, 2025, at a price of $14.20 per share.
  • Following the transaction, Mr. Lamb directly owns 806 shares of the company's common stock.
  • The transaction was signed under Power of Attorney by Mark L. Winget.
  • A Power of Attorney document is included, granting Kevin J. McCarthy, Christopher M. Rohrbacher, and Mark L. Winget the authority to execute Forms 3, 4, and 5 on behalf of David Lamb in connection with Nuveen Investments Closed-End Funds.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to gauge management's confidence in the company's prospects.

Stakeholder Impact

  • The transaction provides information to shareholders regarding insider activity, which can influence investor sentiment.

Key Dates

DateDescription
June 22, 2021Date of execution for the Power of Attorney.
February 20, 2025Date of transaction: David J. Lamb acquired 3,000 shares of common stock.
February 21, 2025Date of Form 4 filing.

Keywords

Form 4, Nuveen S&P 500 BuyWrite Income Fund, BXMX, David J. Lamb, Insider Transaction, Beneficial Ownership, Power of Attorney, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.